P4–312: Preclinical characterization of RO4602522, a novel, selective and orally active monoamine oxidase type B inhibitor for the treatment of Alzheimer's disease. (1st July 2013) - Borroni, Edilio; Wyler, Rene; Messer, Juergen; Nave, Stephane; Cesura, Andrea